Lin Tzu-Lung, Chen Wan-Jiun, Hung Chien-Min, Wong Yea-Lin, Lu Chia-Chen, Lai Hsin-Chih
REVIVEBIO Co., Taipei 115, Taiwan.
Microbio Co., Ltd., Taipei 115, Taiwan.
Int J Mol Sci. 2024 Nov 25;25(23):12660. doi: 10.3390/ijms252312660.
Gut commensals play important roles in maintaining the homeostasis of human health. Previous studies indicated that the abundance of in animal hosts was increased by the administration of prebiotics such as polysaccharides purified from iconic oriental medicinal fungi. Subsequently, was found to exert beneficial effects on the amelioration of multiple chronic inflammation-associated diseases. Even so, during the process of the development of as a next-generation probiotic (NGP), care has to be taken when it is used as a functional food ingredient. In this study, we isolated a novel strain, RV-01, from the feces of a healthy adult and carried out comprehensive analyses of its genomic and phenotypic characteristics. Bioinformatic analysis of RV-01 revealed the absence of potential virulence genes, as well as the presence of genes and traits potentially beneficial to human health, such as the production of short-chain fatty acids, anti-inflammatory lipopolysaccharides, and zwitterionic capsular polysaccharides, as well as immune regulatory proteins. To circumvent any potential side effects, the RV-01 was autoclaved before proceeding to the nonclinical safety assessment. The autoclaved RV-01 retained its anti-inflammatory effect in human colon epithelial cells. In addition to the three genotoxicity assays, 28-day subacute and 90-day subchronic animal toxicity studies (the highest dose tested was equivalent to 8.109 × 10 RV-01 cells/kg body weight/day) were also implemented. The results of all studies were negative for toxicity. These results support the conclusion that autoclaved RV-01 is safe for use as a food ingredient.
肠道共生菌在维持人体健康的稳态中发挥着重要作用。先前的研究表明,通过施用益生元,如从标志性东方药用真菌中纯化的多糖,动物宿主中的[具体微生物名称未给出]丰度会增加。随后,发现[具体微生物名称未给出]对改善多种慢性炎症相关疾病具有有益作用。即便如此,在将[具体微生物名称未给出]开发为下一代益生菌(NGP)的过程中,当将其用作功能性食品成分时仍需谨慎。在本研究中,我们从一名健康成年人的粪便中分离出一种新型[具体微生物名称未给出]菌株RV - 01,并对其基因组和表型特征进行了全面分析。对RV - 01的生物信息学分析表明,其不存在潜在的毒力基因,同时存在可能对人类健康有益的基因和特性,如短链脂肪酸、抗炎脂多糖和两性离子荚膜多糖的产生,以及免疫调节蛋白。为避免任何潜在的副作用,在进行非临床安全性评估之前,将RV - 01进行了高压灭菌处理。经高压灭菌的RV - 01在人结肠上皮细胞中保留了其抗炎作用。除了三项遗传毒性试验外,还进行了为期28天的亚急性和90天的亚慢性动物毒性研究(测试的最高剂量相当于8.109×10个RV - 01细胞/千克体重/天)。所有研究的结果均为毒性阴性。这些结果支持经高压灭菌的RV - 01作为食品成分使用是安全的这一结论。